Clinical pharmacology of locally applied glucocorticoids.
D000085:Acetates; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000890:Anti-Infective Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000378:metabolism; D002176:Candida albicans / Q000187:drug effects; D004336:Drug Antagonism; D004952:Esters; D005233:Fatty Alcohols / Q000494:pharmacology; D005446:Fluocinolone Acetonide / Q000494:pharmacology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D003904:Mitosporic Fungi / Q000187:drug effects* / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012441:Saccharomyces cerevisiae / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013501:Surface-Active Agents / Q000494:pharmacology; D013997:Time Factors
D000085:Acetates; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D004952:Esters; D005233:Fatty Alcohols; D007093:Imidazoles; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols; D013501:Surface-Active Agents; D005446:Fluocinolone Acetonide